Abstract
Economic models are powerful tools to estimate the economic impact of a technology in each scenario. Nevertheless, the process of developing an economic evaluation to multiple scenarios can be a costly and timely consuming process and there is a raising necessity of adaptable cost-effectiveness tools to provide fast support to decision makers. In this context, the treatment costs related to cardiovascular diseases are often brought to the table: the chronic aspect of the conditions and the associated risk factors among other issues also rises attention to health care providers around the world. This study aims to present a calculator of cost-effectiveness and budget impact analysis using the stroke prevention of atrial fibrillation patients who are contraindicated to oral anticoagulation as work model.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
